Train your school staff. Watch the How to Use an EpiPen® (epinephrine injection, USP) Auto-Injector Video.

CLICK HERE

BioRidge Pharma facilitates the certification and fulfillment
of the EpiPen4Schools® orders.

About Us


Mylan partnered with BioRidge Pharma to launch the EpiPen4Schools® program in August 2012. As the marketer and distributor of EpiPen® (epinephrine injection, USP) Auto-Injector, Mylan is committed to improving access to this important treatment. As such, the company offers four free EpiPen® Auto-Injectors to qualifying schools nationwide at no cost.

BioRidge Pharma is a specialty distributor of biotech products and facilitates the certification and fulfillment of all EpiPen4Schools® orders.

Together, Mylan and BioRidge are pleased to make this program available.

About EpiPen® Auto-Injector


EpiPen® and EpiPen Jr® (epinephrine injection, USP) Auto-Injectors are used for the emergency treatment of life-threatening allergic reactions. Each EpiPen 2-Pak® and EpiPen Jr 2-Pak® contains two single auto-injectors, instructions for use and a training device, with no drug product or needle, to help patients become familiar with the administration technique. EpiPen® Auto-Injector should be administered immediately at the first sign of an anaphylactic reaction. EpiPen® Auto-Injector is not a substitute for emergency medical treatment. Patients should seek emergency medical attention immediately following administration. EpiPen® Auto-Injector has been the No. 1 prescribed epinephrine auto-injector for more than 25 years and has three-step simple instructions for use. For more information about EpiPen® Auto-Injector, please visit epipen.com.

About Mylan


Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world’s largest producers of active pharmaceutical ingredients. Every member of our nearly 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.

Mylan Specialty, a subsidiary of Mylan Inc. (NASDAQ: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for respiratory diseases, life-threatening allergic reactions, general anesthesia and psychiatric disorders.

About BioRidge Pharma


BioRidge Pharma provides pharmaceutical and biotech manufacturers with:

  • Logistics Services-Integrated operations solutions that are scaled and customized based on market conditions, demands and delivery service requirements
  • Cost Management-Targeting performance and cost goals by maximizing the value of time and place
  • Inventory Management-Ensuring the right products are in the right place at the right time
  • Storage-Proper storage, temperature control and security for all types of medications
  • Product Tracking-Complete tracking reports for all shipments
  • HIPAA Regulation Compliance Assistance-Guidance provided through the complex regulatory environment

BioRidge also offers specialty pharmacies nationwide access to custom programs that help them grow their business.